Inhaled Cisplatin for NSCLC: Facts and Results.
| Title | Inhaled Cisplatin for NSCLC: Facts and Results. |
| Publication Type | Journal Article |
| Year of Publication | 2019 |
| Authors | Kosmidis, C., Sapalidis K., Zarogoulidis P., Sardeli C., Koulouris C., Giannakidis D., Pavlidis E., Katsaounis A., Michalopoulos N., Mantalobas S., Koimtzis G., Alexandrou V., Tsiouda T., Amaniti A., & Kesisoglou I. |
| Journal | Int J Mol Sci |
| Volume | 20 |
| Issue | 8 |
| Date Published | 2019 Apr 24 |
| ISSN | 1422-0067 |
| Keywords | Administration, Inhalation, Animals, Antineoplastic Agents, Biological Availability, Carcinoma, Non-Small-Cell Lung, Cisplatin, Humans, Lung, Lung Neoplasms, Nebulizers and Vaporizers |
| Abstract | Although we have new diagnostic tools for non-small cell lung cancer, diagnosis is still made in advanced stages of the disease. However, novel treatments are being introduced in the market and new ones are being developed. Targeted therapies and immunotherapy have brought about a bloom in the treatment of non-small cell lung cancer. Still we have to find ways to administer drugs in a more efficient and safe method. In the current review, we will focus on the administration of inhaled cisplatin based on published data. |
| DOI | 10.3390/ijms20082005 |
| Alternate Journal | Int J Mol Sci |
| PubMed ID | 31022839 |
| PubMed Central ID | PMC6514814 |
